接种新冠疫苗后发生格林-巴利综合征死亡病例报告
A Death for Guillain-Barrè Syndrome After Receiving a COVID-19 Vaccine: A Case Report.
作者信息
Coviello Antonio, Iacovazzo Carmine, Vargas Maria, Posillipo Concetta, Sagnelli Francesco, Diglio Pasquale, Cirillo Dario, Servillo Giuseppe
机构信息
Department of Neurosciences, Reproductive and Odontostomatological Sciences, University of Naples "Federico II", Naples, Italy.
出版信息
Clin Med Insights Case Rep. 2024 Oct 5;17:11795476241274692. doi: 10.1177/11795476241274692. eCollection 2024.
The virus SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus 2) causes COVID-19, a potentially fatal disease. The COVID-19 vaccine is indicated for active immunization to prevent COVID-19 caused by SARS-CoV-2. We reported the case of a 66-year-old woman with a medical history of hypertension and anxious-depressive syndrome who developed Guillain Barré Syndrome (GBS) 4 weeks after receiving the COVID-19 vaccine. During the patient's hospital stay, they received cycles of high-dose intravenous immunoglobulin (IVIG) and plasmapheresis treatments.. Despite the treatment, a deterioration of respiratory function led the patient to premature mortality.
严重急性呼吸综合征冠状病毒2（SARS-CoV-2）引发了2019冠状病毒病（COVID-19），这是一种可能致命的疾病。COVID-19疫苗用于主动免疫，以预防由SARS-CoV-2引起的COVID-19。我们报告了一例66岁女性病例，该患者有高血压和焦虑抑郁综合征病史，在接种COVID-19疫苗4周后患上了吉兰-巴雷综合征（GBS）。在患者住院期间，接受了大剂量静脉注射免疫球蛋白（IVIG）和血浆置换治疗。尽管进行了治疗，但呼吸功能恶化导致患者过早死亡。
Zotero 插件